Pulmonx
LUNG
104 hedge funds and large institutions have $581M invested in Pulmonx in 2022 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 43 increasing their positions, 30 reducing their positions, and 20 closing their positions.
43% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 30
12% more capital invested
Capital invested by funds: $520M → $581M (+$61.2M)
1.57% less ownership
Funds ownership: 95.21% → 93.64% (-1.6%)
3% less funds holding
Funds holding: 107 → 104 (-3)
15% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 20
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
78% less call options, than puts
Call options by funds: $210K | Put options by funds: $949K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$12.4M |
| 2 |
JG
Jefferies Group
New York
|
+$5.65M |
| 3 |
DM
Deerfield Management
New York
|
+$4.7M |
| 4 |
Goldman Sachs
New York
|
+$4.3M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$3.68M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pura Vida Investments
New York
|
-$10.1M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$5.45M |
| 3 |
Morgan Stanley
New York
|
-$5.04M |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$4.94M |
| 5 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$4.67M |
LUNG Hedge Fund Activity: Q3 2022 in Review
104 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Pulmonx (LUNG) for Q3 2022, worth a combined $581M — up 12% from $520M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of LUNG and 17 opened new positions — a net loss of 3 holders — while 30 trimmed existing stakes and 43 added.
The largest buyer was Champlain Investment Partners, adding an estimated $12.4M. The largest seller was Pura Vida Investments, cutting an estimated $10.1M.
- 104 institutional investors held Pulmonx (LUNG) as of Q3 2022, down from 107 in Q2 2022.
- Funds reported $581M of Pulmonx stock for Q3 2022, up 12% quarter-over-quarter.
- 17 funds opened new Pulmonx positions in Q3 2022 and 20 closed out, a net change of -3 holders.
- The largest Pulmonx buyer in Q3 2022 was Champlain Investment Partners, an estimated $12.4M added.
- The largest Pulmonx seller in Q3 2022 was Pura Vida Investments, an estimated $10.1M sold.
Based on aggregated 13F filings for Q3 2022.